Products

Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Swine Hepcidin Antimicrobial Peptide (HAMP) ELISA Kit-Competitive

Product Overview

BioVenic Swine Hepcidin Antimicrobial Peptide (HAMP) ELISA Kit-Competitive is designed for the quantitative determination of Swine Hepcidin Antimicrobial Peptide (HAMP) in serum, plasma, tissue homogenate, cell culture supernatant, cell extract, and other biological fluids using a Competitive ELISA method. For research use only. Sandwich ELISA assay kit targeting Swine Hepcidin Antimicrobial Peptide (HAMP) is available. Please inquiry for more information.

Specifications

Assay Type ELISA-Competitive

Specificity The assay kit is specific for Porcine HAMP.

Target Species Swine

Species Reactivity Swine

Detection Range 0.75-60 ng/mL

Reproducibility Intra-Assay: CV < 10%; Inter-Assay: CV < 10%

Assay Time Around 90 min

Sample Requirement Serum, plasma, tissue homogenate, cell culture supernatant, cell extract, and other biological fluids.

Target Information

Hepcidin antimicrobial peptide is encoded by the HAMP gene in pigs. It is a peptide hormone secreted primarily by hepatocytes. As a master regulator of iron homeostasis, it regulates iron availability including its recycling by macrophages, and releasing from hepatic stores.

Target/Biomarker Porcine HAMP

Target Synonym hepcidin antimicrobial peptide; hepcidin; antimicrobial peptide hepcidin

Gene ID 397207

UniProt ID Q8MJ80

Shipping and Storage

This product is shipped with gel ice packs. It is recommended to store at 2-8 °C (Up to 6 months).

Documents

Datasheet

COA

To request a Certificate of Analysis, please enter the Lot No. in the search box. Note: Certificate of Analysis not available for kits.

The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.

References

Kasztura, M. et al. Hemosiderin accumulation in liver decreases iron availability in tachycardia-induced porcine congestive heart failure model. International journal of molecular sciences. 2022, 23: 1026.